Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Selectin ligand antagonist TBC-1269 attenuates renal ischemic reperfusion injury in rats

Nov. 9, 1999

Vasopressin antagonist VPA-985: summary of clinical data presented at ASN

Nov. 9, 1999

Antifibrotic agent pirfenidone slows the progression of glomerulosclerosis

Nov. 8, 1999

News from ASN: PDGF tyrosine kinase is a target for intervention in renal diseases

Nov. 8, 1999

Agents for urinary incontinence, pollakiuria in early development at Fujisawa

Nov. 4, 1999

U Penn researchers identify new target for treatment of erectile dysfunction

Nov. 2, 1999

Proof-of-concept trial begins for Vivus's oral PE compounds

Oct. 21, 1999

AnorMed initiates phase III clinical trials in U.S. for Lambda

Oct. 20, 1999

FDA approves Rochester Medical's FemSoft Insert for female stress urinary incontinence

Oct. 5, 1999

New muscarinic antagonists developed at Roche

Oct. 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...